231115072.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

231115072.Pdf View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Dartmouth Digital Commons (Dartmouth College) Dartmouth College Dartmouth Digital Commons Open Dartmouth: Faculty Open Access Articles 8-2003 CCR5 Mediates Specific iM gration of Toxoplasma Gondii—Primed CD8+ Lymphocytes to Inflammatory Intestinal Epithelial Cells Souphalone Luangsay Dartmouth College Lloyd H. Kasper Dartmouth College Nicolas Rachinel Dartmouth College Laurie A. Minns Dartmouth College Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa Part of the Digestive System Diseases Commons, and the Gastroenterology Commons Recommended Citation Luangsay, Souphalone; Kasper, Lloyd H.; Rachinel, Nicolas; and Minns, Laurie A., "CCR5 Mediates Specific iM gration of Toxoplasma Gondii—Primed CD8+ Lymphocytes to Inflammatory Intestinal Epithelial Cells" (2003). Open Dartmouth: Faculty Open Access Articles. 593. https://digitalcommons.dartmouth.edu/facoa/593 This Article is brought to you for free and open access by Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Faculty Open Access Articles by an authorized administrator of Dartmouth Digital Commons. For more information, please contact [email protected]. GASTROENTEROLOGY 2003;125:491–500 CCR5 Mediates Specific Migration of Toxoplasma gondii–Primed CD8؉ Lymphocytes to Inflammatory Intestinal Epithelial Cells SOUPHALONE LUANGSAY,* LLOYD H. KASPER,* NICOLAS RACHINEL,* LAURIE A. MINNS,* FRANCK J. D. MENNECHET,* ALAIN VANDEWALLE,‡ and DOMINIQUE BUZONI–GATEL§ *Departments of Microbiology and Immunology and Medicine, Dartmouth Medical School, Lebanon, New Hampshire; ‡INSERM Unite´ 478, Faculte´deMe´decine Xavier Bichat, Paris, France; and §De´partement de Parasitologie, Institut Pasteur, and De´partement de Sante´ Animale, Institut National de la Recherche Agronomique, Paris, France Background & Aims: Toxoplasma gondii, an obligate in- creted at the surface of intestinal epithelial cells (IECs) tracellular parasite, can invade intestinal epithelial cells play a critical role in the initiation and modulation of the and elicit a robust Th1 immune response. In this model immune response to various pathogens.1 In humans, ؉ of intestinal inflammation, CD8 intraepithelial lym- IECs from inflamed intestines secrete inflammatory cy- phocytes (IELs) secrete transforming growth factor tokines; in mice, intestinal lesions due to invasive patho- (TGF)-␤, which appears necessary for the maintenance gens are more frequently characterized by acute neutro- of homeostasis in the intestine. However, the mecha- nism responsible for the IEL migration to the inflamed phil infiltrations associated with increased levels of intestine is still unclear. Methods: An in vitro coculture macrophage inflammatory protein (MIP)-2 produced by cell system was used to quantify the IEL attraction by an infected IECs.2,3 Other chemokines may act as chemoat- infected intestinal epithelial cell line (m-ICcl2). We used tractants for macrophages/monocytes/neutrophils and/or CCR5-deficient mice to determine which chemokine re- lymphocytes.4 ceptor–chemokine interaction could be responsible for Intestinal intraepithelial lymphocytes (IELs), mainly the recruitment of antigen-specific CD8؉ IELs to the composed of CD8␣ϩ subsets of lymphocytes (CD8␣␣ϩ small intestine for the promotion of parasite clearance and CD8␣␤ϩ IELs), are present in the gastrointestinal and host recovery. Results: We observed increased ex- tract and express chemokine receptors, including CCR2, pression of several chemokine receptors (CCR1, CCR2, CXCR3, CCR5, and CCR9. Some of these receptors are CCR5, CXCR3) in the infected ileum. In particular, CCR5 up-regulated during intestinal inflammation and are per- expression was markedly increased in antigen-primed haps critical in lymphocyte localization within intestinal CD8؉ IELs. Experiments using recombinant chemokines mucosa. Recently, a specialized interaction has been de- as well as blocking antibodies showed that macrophage ϩ ϩ inflammatory protein (MIP)-1␣ and MIP-1␤ were critical scribed between both CD8 IELs and CD4 T cells from for their homing. CD8؉ IELs isolated from CCR5-defi- the lamina propria expressing CCR9 and IECs through cient mice (CCR5؊/؊), despite their high production of the interaction with its ligand, the thymus-expressed TGF-␤ and overexpression of activation markers, were chemokine (CCL25), which appears to be highly ex- 5,6 impaired in their ability to migrate in vitro to the m-ICcl2 pressed in crypt intestinal cells. Such specific chemo- monolayer or in vivo to the inflamed intestine after kine-lymphocyte receptor interaction in the normal gas- adoptive transfer. Conclusions: Our data emphasize the trointestinal tract suggests that the expression of biologic role of CCR5 as an important component in the chemokines by differentiated epithelium represents an -migration of intraepithelial CD8؉ T cells and the regula tion of the inflammatory response following parasite infection. Abbreviations used in this paper: CFSE, 5(6) carboxyfluorescein diacetate, succinimidyl ester; IEC, intestinal epithelial cell; IEL, intra- epithelial lymphocyte; IL, interleukin; IP-10, interferon ␥–inducible 10-kilodalton protein; MIP, macrophage inflammatory protein; MCP, principal biologic function of the intestinal muco- monocyte chemoattractant protein; RANTES, regulated upon activa- Asal surface is to maintain immunologic homeostasis tion, normal T cell expressed and secreted protein; TGF, transforming in response to foreign antigens. The enterocytes lining growth factor; WT, wild-type. © 2003 by the American Gastroenterological Association the villus wall of the intestine form a tight barrier 0016-5085/03/$30.00 against potentially invasive pathogens. Chemokines se- doi:10.1016/S0016-5085(03)00903-X 492 LUANGSAY ET AL. GASTROENTEROLOGY Vol. 125, No. 2 important mechanism for specialized immune responses. CD8␤ϩ IELs were purified by incubation with either anti- This interaction may allow for homeostatic balance in the CD8␣ microbeads (Miltenyi Biotec, Auburn, CA) or anti- normal gut.6,7 CD8␤ antibody (BD Pharmingen, San Diego, CA) followed by Toxoplasma gondii, an obligate intracellular parasite anti-rat immunoglobulin G microbeads (Miltenyi Biotec) and acquired by oral infection and responsible for acute and separated with a magnetically activated cell sorting column ϩ ϩ lethal ileitis in susceptible C57BL/6 mice, can invade (Miltenyi Biotec). CD8␣ and CD8␤ staining (BD Pharm- IECs, eliciting a robust immune response that is associ- ingen) confirmed 98% pure populations. Surface expression ␣ ated with increased production of chemokines.8,9 In T. was assessed with CCR5, E (CD103), CD25, Ly-6C, and gondii–infected and –inflamed intestines, the composi- Ox40 (CD134) (BD Pharmingen). tion of infiltrating cells is predominantly represented by Culture of m-IC Cells and Infection CD8ϩ IELs and CD4ϩ lymphocytes, which confer the cl2 by T. gondii main components of protective immunity to T. gon- ϩ b 14 dii.9–11 The CD8 IELs have been shown to promote IECs from the m-ICcl2 cell line (C57BL/6, H-2 ) were host recovery and parasite clearance. When adoptively seeded upside down on collagen I–coated Transwell filters transferred, infiltrating CD8␣␤ TCR␣␤ IELs provide (5 ϫ 105 cells/filter; ID, 6.5 mm; pore size, 3 ␮m; Costar long-term immunity and protect mice against a lethal Transwell, Fisher Scientific, Pittsburgh, PA) and cultured for parasite challenge in a transforming growth factor 10 days in a modified defined medium as previously de- 8,9 (TGF)-␤–dependent manner.8,10 The preferential re- scribed. The integrity of the infected monolayer was con- cruitment of these cells to infected intestinal sites ap- firmed microscopically before each experiment and infected pears to be critical for the control of the inflammatory with 2:1 parasites cells. For the in vitro infection, tachyzoits from the RH strain of T. gondii were used. All experiments cellular response.12 Although the ␣4␤7 and ␣E␤7 inte- were performed on 3 separate filters for each condition tested grins expressed at the cell surface of lymphocytes may and then repeated in at least 3 different experiments. partially explain IEL trafficking,12 other molecules in- cluding IEC-expressed chemokines may act as chemoat- In Vitro Migration Assay tractants.8,9 ␣ϩ In this study, we show that the secretion of beta Unprimed and primed CD8 IELs incubated with a ␮ chemokines MIP-1␣ (CCL3) and MIP-1␤ (CCL4) by cell dye 5-chloromethylflurorescein diacetate (10 mol/L) enterocytes can orchestrate the recruitment of CD8ϩ (Molecular Probes, Eugene, OR) were added to the upper IELs via CCR5 to enhance the immune response against chamber of confluent m-ICcl2 cells grown on Transwell as previously described (5 ϫ 105 IELs/filter; Costar Transwell) T. gondii infection. These results show the immunologic without or with blocking antibodies to MIP-1␣ and MIP-1␤ potential of IECs expressing specific chemokines for the (1 and 10 ␮g/mL) or with their irrelevant control anti-goat trafficking and control of intestinal IELs in this patho- immunoglobulin G (R&D Systems, Minneapolis, MN). m- gen-driven model of intestinal inflammatory disease. ICcl2 cells and IELs were incubated for 4 hours at 37°C. To visualize the IELs in the monolayer, filters were stained with Materials and Methods propidium iodide and rhodamine-phalloidin (Molecular Mice and T. gondii Infection Probes) and observed by confocal laser scanning microscopy (MRC 1024; Bio-Rad,
Recommended publications
  • Th2 Effector Lymphocytes Regulatory and + Cells Enriched for FOXP3
    CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3 + Regulatory and Th2 Effector Lymphocytes This information is current as Dulce Soler, Tobias R. Chapman, Louis R. Poisson, Lin of September 27, 2021. Wang, Javier Cote-Sierra, Mark Ryan, Alice McDonald, Sunita Badola, Eric Fedyk, Anthony J. Coyle, Martin R. Hodge and Roland Kolbeck J Immunol 2006; 177:6940-6951; ; doi: 10.4049/jimmunol.177.10.6940 Downloaded from http://www.jimmunol.org/content/177/10/6940 References This article cites 68 articles, 27 of which you can access for free at: http://www.jimmunol.org/content/177/10/6940.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 27, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3؉ Regulatory and Th2 Effector Lymphocytes Dulce Soler,1 Tobias R.
    [Show full text]
  • Polyclonal Anti-CCR1 Antibody
    FabGennix International, Inc. 9191 Kyser Way Bldg. 4 Suite 402 Frisco, TX 75033 Tel: (214)-387-8105, 1-800-786-1236 Fax: (214)-387-8105 Email: [email protected] Web: www.FabGennix.com Polyclonal Anti-CCR1 antibody Catalog Number: CCR1-112AP General Information Product CCR1 Antibody Affinity Purified Description Chemokine (C-C motif) receptor 1 Antibody Affinity Purified Accession # Uniprot: P32246 GenBank: AAH64991 Verified Applications ELISA, WB Species Cross Reactivity Human Host Rabbit Immunogen Synthetic peptide taken within amino acid region 1-50 on human CCR1 protein. Alternative Nomenclature C C chemokine receptor type 1 antibody, C C CKR 1 antibody, CCR1 antibody, CD191 antibody, CMKBR 1 antibody, CMKR1 antibody, HM145 antibody, LD78 receptor antibody, Macrophage inflammatory protein 1 alpha /Rantes receptor antibody, MIP-1alpha-R antibody, MIP1aR antibody, RANTES receptor antibody, SCYAR1 antibody Physical Properties Quantity 100 µg Volume 200 µl Form Affinity Purified Immunoglobulins Immunoglobulin & Concentration 0.65-0.75 mg/ml IgG in antibody stabilization buffer Storage Store at -20⁰C for long term storage. Recommended Dilutions DOT Blot 1:10,000 ELISA 1:10,000 Western Blot 1:500 Related Products Catalog # FITC-Conjugated CCR1.112-FITC Antigenic Blocking Peptide P-CCR1.112 Western Blot Positive Control PC-CCR1.112 Tel: (214)-387-8105, 1-800-786-1236 Fax: (214)-387-8105 Email: [email protected] Web: www.FabGennix.com Overview: Chemokine receptors represent a subfamily of ~20 GPCRs that were originally identified by their roles in immune cell trafficking. Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and RANTES, members of the beta chemokine family of leukocyte chemo- attractants, bind to a common seven-transmembrane-domain human receptor.
    [Show full text]
  • GM-CSF Modulates the Migratory Phenotype of Vaccine-Induced T Cells by Enhancing CXCR3 Expression
    GM-CSF modulates the migratory phenotype of vaccine-induced T cells by enhancing CXCR3 expression Il-Kang Na Carmen Scheibenbogen Ulrich Keilholz Department of Hematology, Oncology and Transfusion Medicine, Charité Berlin, Campus Benjamin Franklin, Germany. Background Selective chemokine receptor Inflammatory Local tissue microenvironment CXCR3 Tumor tissue CCR4 Skin CCR9 Tissue specific dendritic cells Small intestine Aim of the study Analysis of • Expression of chemokine receptors CXCR3 and CCR4 on vaccine-induced T cells. • Influence of GM-CSF as vaccine adjuvant on chemokine receptor expression. Materials & Methods • Patient samples: stage III/ IV melanoma 1) Tyrosinase peptide + KLH + GM-CSF 2 cohorts 2) Tyrosinase peptide + KLH • T cell response assessment by IFNγ flow cytometry analysis Phase I trial of tyrosinase peptide with adjuvants GM-CSF and KLH 50 50 40 40 30 30 Tyr specific 20 20 PBMC 6 10 10 / 10 0 0 before P13 P14 P15 P15 P16 P17 P17 P18 P18 P19 P11 P11 P12 P12 P13 P31 P32 P33 P34 P35 P35 P36 P36 P37 P38 P38 P39 P40 # 2 # 4 T cells Tyr + KLH Tyr + KLH + GM-CSF # 6 ng i 250 250 200 200 150 150 KLH specific IFNg-secret 100 100 50 50 0 0 P21 P22 P23 P24 P25 P26 P27 P28 P29 P30 P31 P32 P33 P34 P35 P36 P37 P38 P39 Patient identification Scheibenbogen et al. 2003 CXCR3 expression on KLH-specific T cells no antigen KLH 25.2 0.02 24.7 0.06 74.7 0.04 75.1 0.2 Tyr + KLH cohort CXCR3 46.6 0.02 46.0 0.09 52.1 0.01 51.9 0.06 Tyr + KLH + GM-CSF cohort IFNγ CXCR3, CCR4 and CCR9 expression on KLH-specific T cells with GM-CSF without
    [Show full text]
  • CCR6 IL-17 Express the Chemokine Receptor Human T Cells That Are
    Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6 This information is current as Satya P. Singh, Hongwei H. Zhang, John F. Foley, Michael of September 26, 2021. N. Hedrick and Joshua M. Farber J Immunol 2008; 180:214-221; ; doi: 10.4049/jimmunol.180.1.214 http://www.jimmunol.org/content/180/1/214 Downloaded from References This article cites 58 articles, 27 of which you can access for free at: http://www.jimmunol.org/content/180/1/214.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 26, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR61 Satya P. Singh, Hongwei H. Zhang, John F. Foley, Michael N. Hedrick, and Joshua M. Farber2 Some pathways of T cell differentiation are associated with characteristic patterns of chemokine receptor expression.
    [Show full text]
  • Research Article CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation
    Hindawi Publishing Corporation Mediators of Inflammation Volume 2016, Article ID 3635809, 16 pages http://dx.doi.org/10.1155/2016/3635809 Research Article CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation C. López-Pacheco,1,2 G. Soldevila,2 G. Du Pont,1,2 R. Hernández-Pando,3 and E. A. García-Zepeda1,2 1 CBRL, Ciudad de Mexico,´ Mexico 2Departamento de Inmunolog´ıa, Instituto de Investigaciones Biomedicas,´ Universidad Nacional Autonoma´ de Mexico,´ 04510 Ciudad de Mexico,´ Mexico 3Departamento de Patolog´ıa Experimental, Instituto Nacional de Ciencias Medicas´ y Nutricion´ “Salvador Zubiran”,´ Tlalpan, 14080 Ciudad de Mexico,´ Mexico Correspondence should be addressed to E. A. Garc´ıa-Zepeda; [email protected] Received 9 May 2016; Accepted 7 August 2016 Academic Editor: Carolina T. Pineiro˜ Copyright © 2016 C. Lopez-Pacheco´ et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Airway inflammation is the most common hallmark of allergic asthma. Chemokine receptors involved in leukocyte recruitment are closely related to the pathology in asthma. CCR9 has been described as a homeostatic and inflammatory chemokine receptor, but its role and that of its ligand CCL25 during lung inflammation remain unknown. To investigate the role of CCR9 as a modulator of airway inflammation, we established an OVA-induced allergic inflammation model in CCR9-deficient mice. Here, we report the expression of CCR9 and CCL25 as early as 6 hours post-OVA challenge in eosinophils and T-lymphocytes.
    [Show full text]
  • Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
    cancers Review Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them? Justine Cinier 1,†, Margaux Hubert 1,†, Laurie Besson 1, Anthony Di Roio 1 ,Céline Rodriguez 1, Vincent Lombardi 2, Christophe Caux 1,‡ and Christine Ménétrier-Caux 1,*,‡ 1 University of Lyon, Claude Bernard Lyon 1 University, INSERM U-1052, CNRS 5286 Centre Léon Bérard, Cancer Research Center of Lyon (CRCL), 69008 Lyon, France; [email protected] (J.C.); [email protected] (M.H.); [email protected] (L.B.); [email protected] (A.D.R.); [email protected] (C.R.); [email protected] (C.C.) 2 Institut de Recherche Servier, 125 Chemin de Ronde, 78290 Croissy-sur-Seine, France; [email protected] * Correspondence: [email protected] † Co-first authorship. ‡ Co-last authorship. Simple Summary: The immune response against cancer is generated by effector T cells, among them cytotoxic CD8+ T cells that destroy cancer cells and helper CD4+ T cells that mediate and support the immune response. This antitumor function of T cells is tightly regulated by a particular subset of CD4+ T cells, named regulatory T cells (Tregs), through different mechanisms. Even if the complete inhibition of Tregs would be extremely harmful due to their tolerogenic role in impeding autoimmune diseases in the periphery, the targeted blockade of their accumulation at tumor sites or their targeted Citation: Cinier, J.; Hubert, M.; depletion represent a major therapeutic challenge. This review focuses on the mechanisms favoring Besson, L.; Di Roio, A.; Rodriguez, C.; Treg recruitment, expansion and stabilization in the tumor microenvironment and the therapeutic Lombardi, V.; Caux, C.; strategies developed to block these mechanisms.
    [Show full text]
  • Colorectal Cancer-Infiltrating T Lymphocytes Display a Distinct
    Löfroos et al. Eur J Med Res (2017) 22:40 DOI 10.1186/s40001-017-0283-8 European Journal of Medical Research RESEARCH Open Access Colorectal cancer‑infltrating T lymphocytes display a distinct chemokine receptor expression profle Ann‑Britt Löfroos1,2†, Mohammad Kadivar2†, Sabina Resic Lindehammer1,2 and Jan Marsal1,2,3* Abstract Background: T lymphocytes exert important homeostatic functions in the healthy intestinal mucosa, whereas in case of colorectal cancer (CRC), infltration of T lymphocytes into the tumor is crucial for an efective anti-tumor immune response. In both situations, the recruitment mechanisms of T lymphocytes into the tissues are essential for the immunological functions deciding the outcome. The recruitment of T lymphocytes is largely dependent on their expression of various chemokine receptors. The aim of this study was to identify potential chemokine receptors involved in the recruitment of T lymphocytes to normal human colonic mucosa and to CRC tissue, respectively, by examining the expression of 16 diferent chemokine receptors on T lymphocytes isolated from these tissues. Methods: Tissues were collected from patients undergoing bowel resection for CRC. Lymphocytes were isolated through enzymatic tissue degradation of CRC tissue and nearby located unafected mucosa, respectively. The expres‑ sion of a broad panel of chemokine receptors on the freshly isolated T lymphocytes was examined by fow cytometry. Results: In the normal colonic mucosa, the frequencies of cells expressing CCR2, CCR4, CXCR3, and CXCR6 dif‑ fered signifcantly between ­CD4+ and ­CD8+ T lymphocytes, suggesting that the molecular mechanisms mediating T lymphocyte recruitment to the gut difer between ­CD4+ and ­CD8+ T lymphocytes.
    [Show full text]
  • The Abnormal Expression of CCR4 and CCR6 on Tregs in Rheumatoid Arthritis
    Int J Clin Exp Med 2015;8(9):15043-15053 www.ijcem.com /ISSN:1940-5901/IJCEM0003430 Original Article The abnormal expression of CCR4 and CCR6 on Tregs in rheumatoid arthritis Ning Li1*, Wei Wei2*, Feng Yin3*, Maogen Chen4, Tian R Ma5, Qiang Wu3, Jie R Zhou1, Song-Guo Zheng4,6, Jie Han1 Departments of 1Rheumatology, 3Osteology, Shanghai East Hospital, 6Institute of Immunology, Tongji University School of Medicine, Shanghai, 200120, China; 2Department of Rheumatology, Yuyao People’s Hospital, Yuyao 315400, Zhejiang, China; 4Division of Rheumatology & Immunology, Department of Medicine, Keck School of Medicine of The University of Southern California, Los Angeles 90033, CA, USA; 5Department of Rheumatology, Ningbo Women and Children’s Hospital, Ningbo 315012, Zhejiang, China. *Equal contributors. Received October 28, 2014; Accepted January 7, 2015; Epub September 15, 2015; Published September 30, 2015 Abstract: The study aims to investigate the frequency of CD4+CD25+Foxp3+CD127- T regulatory cells (Tregs) and the expression of CCR4, CCR6 and/or other chemokine receptors on Tregs in peripheral blood (PB) in patients with rheumatoid arthritis, as well as in PB, draining lymph nodes (dLNs), lungs and spleens in collagen-induced arthritis (CIA) mice. We also study the possible role of CCR4 and CCR6 abnormal expression on Tregs in RA pa- tients and the underlying mechanisms. The numbers of Tregs and chemokine receptors expression profile on Tregs in PB from RA patients and healthy controls were investigated by flow cytometry (FACS) using three- or four-color intracellular staining. DBA/1 Foxp3gfp reporter mice were immunized with collagen II (CII) emulsified with CFA.
    [Show full text]
  • Three Chemokine Receptors Cooperatively Regulate Homing of Hematopoietic Progenitors to the Embryonic Mouse Thymus
    Three chemokine receptors cooperatively regulate homing of hematopoietic progenitors to the embryonic mouse thymus Lesly Calderón and Thomas Boehm1 Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, D-79108 Freiburg, Germany Edited* by Max D. Cooper, Emory University, Atlanta, GA, and approved March 25, 2011 (received for review November 2, 2010) The thymus lacks self-renewing hematopoietic cells, and thymopoi- These results were interpreted as indicating that Ccr9/Ccl25 and esis fails rapidly when the migration of progenitor cells to the Ccr7/Ccl21 are essential only for the prevascular stage of thymus thymus ceases. Hence, the process of thymus homing is an essen- colonization. Interestingly, two recent reports demonstrate that tial step for T-cell development and cellular immunity. Despite de- adult mice lacking both Ccr7 and Ccr9 display severe reductions cades of research, the molecular details of thymus homing have not in the number of early thymic progenitors and suggest that been elucidated fully. Here, we show that chemotaxis is the key compensatory expansion of intrathymic populations could ex- mechanism regulating thymus homing in the mouse embryo. We plain, at least in part, normal thymic cellularity (13, 14). Although determined the number of early thymic progenitors in the thymic these studies ascribe important roles to Ccr9 and Ccr7 in thymus rudimentsofmicedeficient for one, two, or three of the chemokine colonization, these receptors do not appear to be essential, sug- receptor genes, chemokine (C-C motif) receptor 9 (Ccr9), chemokine gesting that other molecules might be involved, for instance (C-C motif) receptor 7 (Ccr7), and chemokine (C-X-C motif) receptor 4 Cxcl12 and its receptor Cxcr4.
    [Show full text]
  • CXCL16 Stimulates Antigen-Induced MAIT Cell Accumulation but Trafficking During Lung Infection Is CXCR6-Independent
    ORIGINAL RESEARCH published: 07 August 2020 doi: 10.3389/fimmu.2020.01773 CXCL16 Stimulates Antigen-Induced MAIT Cell Accumulation but Trafficking During Lung Infection Is CXCR6-Independent Huifeng Yu 1, Amy Yang 1, Ligong Liu 2,3, Jeffrey Y. W. Mak 2,3, David P. Fairlie 2,3 and Siobhan Cowley 1* 1 Laboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States, 2 Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia, 3 Australian Research Council Centre of Excellence in Advanced Molecular Imaging, The University of Queensland, Brisbane, QLD, Australia Mucosa-associated invariant T (MAIT) cells are a unique T cell subset that contributes to protective immunity against microbial pathogens, but little is known about the role of chemokines in recruiting MAIT cells to the site of infection. Pulmonary infection with Francisella tularensis live vaccine strain (LVS) stimulates the accrual of large numbers Edited by: Ildiko Van Rhijn, of MAIT cells in the lungs of mice. Using this infection model, we find that MAIT cells Brigham and Women’s Hospital, are predominantly CXCR6+ but do not require CXCR6 for accumulation in the lungs. Harvard Medical School, However, CXCR6 does contribute to long-term retention of MAIT cells in the airway United States Reviewed by: lumen after clearance of the infection. We also find that MAIT cells are not recruited Franz Puttur, from secondary lymphoid organs and largely proliferate in situ in the lungs after infection. Imperial College London, Nevertheless, the only known ligand for CXCR6, CXCL16, is sufficient to drive MAIT cell United Kingdom Marianne Quiding-Järbrink, accumulation in the lungs in the absence of infection when administered in combination University of Gothenburg, Sweden with the MAIT cell antigen 5-OP-RU.
    [Show full text]
  • CXCR6 Regulates Localization of Tissue-Resident Memory CD8 T Cells to the Airways
    Published Online: 26 September, 2019 | Supp Info: http://doi.org/10.1084/jem.20181308 Downloaded from jem.rupress.org on September 26, 2019 ARTICLE CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways Alexander N. Wein1*, Sean R. McMaster1*, Shiki Takamura2*, Paul R. Dunbar1, Emily K. Cartwright1, Sarah L. Hayward1, Daniel T. McManus1, Takeshi Shimaoka3, Satoshi Ueha3, Tatsuya Tsukui4, Tomoko Masumoto2, Makoto Kurachi5, Kouji Matsushima3, and Jacob E. Kohlmeier1,6 Resident memory T cells (TRM cells) are an important first-line defense against respiratory pathogens, but the unique contributions of lung TRM cell populations to protective immunity and the factors that govern their localization to different compartments of the lung are not well understood. Here, we show that airway and interstitial TRM cells have distinct effector functions and that CXCR6 controls the partitioning of TRM cells within the lung by recruiting CD8 TRM cells to the −/− airways. The absence of CXCR6 significantly decreases airway CD8 TRM cells due to altered trafficking of CXCR6 cells within the lung, and not decreased survival in the airways. CXCL16, the ligand for CXCR6, is localized primarily at the respiratory epithelium, and mice lacking CXCL16 also had decreased CD8 TRM cells in the airways. Finally, blocking CXCL16 inhibited the steady-state maintenance of airway TRM cells. Thus, the CXCR6/CXCL16 signaling axis controls the localization of TRM cells to different compartments of the lung and maintains airway TRM cells. Introduction Over the past decade, resident memory T cells (TRM cells) have (Campbell et al., 1999; Schaerli et al., 2004; Sigmundsdottir been recognized as a distinct population from either central or et al., 2007).
    [Show full text]
  • Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma ASHLEY C
    ANTICANCER RESEARCH 36 : 4013-4018 (2016) Chemokine and Chemokine Receptor Profiles in Metastatic Salivary Adenoid Cystic Carcinoma ASHLEY C. MAYS, XIN FENG, JAMES D. BROWNE and CHRISTOPHER A. SULLIVAN Department of Otolaryngology, Wake Forest School of Medicine, Winston Salem, NC, U.S.A. Abstract. Aim: To characterize the chemokine pattern in distant metastasis (2-5). According to Ko et al. , 75% of metastatic salivary adenoid cystic carcinoma (SACC). patients with initial nodal involvement eventually developed Materials and Methods: Real-time polymerase chain distant metastasis. Patients with lung metastasis have a poor reaction (RT-PCR) was used to compare chemokine and prognosis (6). chemokine receptor gene expression in two SACC cell lines: The development of distant metastatic disease is the chief SACC-83 and SACC-LM (lung metastasis). Chemokines and cause for mortality (7, 8). Primary treatment is complete receptor genes were then screened and their expression surgical resection when feasible with adjuvant radiotherapy. pattern characterized in human tissue samples of non- The role of chemotherapy is debatable. Treatment of recurrent SACC and recurrent SACC with perineural metastatic ACC has been difficult to date due to lack of invasion. Results: Expression of chemokine receptors specific targets for metastatic cells (1). Though the steps that C5AR1, CCR1, CCR3, CCR6, CCR7, CCR9, CCR10, must occur in the metastatic event are well characterized, it CXCR4, CXCR6, CXCR7, CCRL1 and CCRL2 were higher remains unclear why or how ACC cells ultimately “choose” in SACC-83 compared to SACC-LM. CCRL1, CCBP2, or are ”chosen” to migrate to a specific metastatic site. A CMKLR1, XCR1 and CXCR2 and 6 chemokine genes mounting body of evidence suggests that cytokine-like (CCL13, CCL27, CXCL14, CMTM1, CMTM2, CKLF) were molecules called chemokines play a significant role in more highly expressed in tissues of patients without tumor directing the cellular traffic in metastatic melanoma, lung, recurrence/perineural invasion compared to those with breast and ACC cancers (9-15).
    [Show full text]